Related party disclosures (Tables)

12 Months Ended

Dec. 31, 2020

Sales/purchase transactions with related parties

Transactions entered into and trading balances outstanding at December 31 are as follows:

	2020				2019				2018
	Sales to related party £000’s		Purchases from related party £000’s		Sales to related party £000’s		Purchases from related party £000’s		Sales to related party £000’s		Purchases from related party £000’s
Aigenpulse Limited		-		-		-		500		-		729
Adaptimmune Limited		-		-		-		-		69		-
Malin Life Sciences Holdings Limited		-		-		-		-		-		2
Oxford Nanosystems Limited		-		-		-		-		2		-
Oxford Innovation Ltd		-		-		-		30		-		13
		-		-		-		530		71		744

Remuneration of key management personnel

The remuneration of the directors and executive officers (excluding non-executive directors), who are the key management personnel of the Group, is set out below in aggregate for each of the categories specified in IAS 24, ‘Related Party Disclosures

	2020 £000’s		2019 £000’s		2018 £’000’s
Short-term employee benefits		3,421		6,502		4,435
Share-based payments		5,602		3,667		270
		9,023		10,169		4,705